Biohaven Execs Trade $9.93: CEO Sells, Senior Clinical VP Buys – Insider Moves Hint at Long‑Term Confidence Amid Price Decline
Insider buying at Biohaven signals cautious confidence amid a 68 % price drop, hinting at long‑term value and potential upside.
4 minutes to read